Impact of Long-Term Dienogest Therapy on Quality of Life in Asian Women with Endometriosis: the Prospective Non-Interventional Study ENVISIOeN
Authors:
Open Access
- 2 February 2022
- journal article
- research article
- Published by Springer Nature in Reproductive Sciences
- Vol. 29 (4) , 1157-1169
Abstract
Several clinical trials in women with endometriosis demonstrated that dienogest reduces endometrial lesions and improves health-related quality of life (HRQoL). To assess HRQoL in dienogest-treated patients in real-world setting, we conducted a prospective, non-interventional study in 6 Asian countries. Women aged ≥18 years with clinical or surgical diagnosis of endometriosis, presence of endometriosis-associated pelvic pain (EAPP) and initiating dienogest therapy were enrolled. The primary objective was to evaluate HRQoL using the Endometriosis Health Profile-30 (EHP-30) questionnaire. The secondary objectives included analysis of EAPP, satisfaction with dienogest, endometriosis symptoms and bleeding patterns. 887 patients started dienogest therapy. Scores for all EHP-30 scales improved with the largest mean changes at month 6 and 24 in scale pain (−28.9 ± 27.5 and − 34 ± 28.4) and control and powerlessness (−23.7 ± 28.2 and − 28.5 ± 26.2). Mean EAPP score change was −4.6 ± 3.0 for both month 6 and 24 assessments. EAPP decrease was similar in surgically and only clinically diagnosed patients. From baseline to month 24, rates of normal bleeding decreased (from 85.8% to 17.5%) while rates of amenorrhea increased (from 3.5% to 70.8%). Majority of patients and physicians were satisfied with dienogest. Over 80% of patients reported symptoms improvement. 39.9% of patients had drug-related treatment-emergent adverse events, including vaginal hemorrhage (10.4%), metrorrhagia (7.3%) and amenorrhea (6.4%). In conclusion, dienogest improves HRQoL and EAPP in the real-world setting in women with either clinical or surgical diagnosis of endometriosis. Dienogest might be a promising first-line treatment option for the long-term management of debilitating endometriosis-associated symptoms.NCT02425462, 24 April 2015.Keywords
This publication has 48 references indexed in Scilit:
- Health-related quality of life in women with endometriosis: a systematic reviewJournal of Ovarian Research, 2012
- Reduced pelvic pain in women with endometriosis: efficacy of long-term dienogest treatmentArchives of Gynecology and Obstetrics, 2011
- Evaluation of Quality of Life and Sexual Satisfaction in Women Suffering from Chronic Pelvic Pain With or Without EndometriosisThe Journal of Sexual Medicine, 2011
- Quality of life associated to chronic pelvic pain is independent of endometriosis diagnosis-a cross-sectional surveyHealth and Quality of Life Outcomes, 2011
- Long‐term use of dienogest for the treatment of endometriosisJournal of Obstetrics and Gynaecology Research, 2009
- A dose‐ranging study to determine the efficacy and safety of 1, 2, and 4 mg of dienogest daily for endometriosisInternational Journal of Gynecology & Obstetrics, 2009
- Recurrence of endometriosis and its controlHuman Reproduction Update, 2009
- Laparoscopic surgery for endometriosis: How often do we need to re-operate?Journal of Obstetrics and Gynaecology, 2008
- Development of an endometriosis quality-of-life instrument: The Endometriosis Health Profile-30Obstetrics & Gynecology, 2001
- Endometriosis and RaceAustralian and New Zealand Journal of Obstetrics and Gynaecology, 1992